Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the Fertility Drugs Market, and What Are the Key Drivers?

There has been robust growth in the fertility drugs market size in the past few years. It is projected to increase from a valuation of $3.13 billion in 2024 to reach $3.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.3%. The considerable growth observed in the historical period can be traced back to rising infertility rates, advancements in reproductive healthcare, developments in assisted reproductive technologies (ART), and postponement of childbirth.

The market for fertility drugs is projected to exhibit significant expansion in the coming years, with the expectation to reach $4.39 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.9%. This growth trajectory throughout the forecast period can be ascribed to factors such as the increasing elderly population, changes in lifestyle factors, developments in assisted reproductive technologies (ART), and the emergence of personalized medicine. Key upcoming trends during the forecast period encompass advancements in ART, the evolution of ovulation-stimulating drugs, and the progression in hormone treatment.

What Strategic Factors Are Influencing the Accelerated Growth of the Fertility Drugs Market?

The market for fertility medications is expanding due to the growing prevalence of infertility worldwide. Infertility, defined as the failure to become pregnant after 12 months of trying, is primarily treated using fertility drugs. These medications are common for treating infertility in both men and women. Heightened infertility rates are often linked to physiological issues, hormonal imbalances, and lifestyle or environmental factors. Fertility medications play a significant role in managing ovulation cycles in women to treat fertility issues, thereby impacting the sales of these drugs. For example, the Office for National Statistics, a UK-based branch of the UK Statistics Authority, reported in February 2024 that the total fertility rate (TFR) fell to 1.49 children per woman in 2022, a drop from 1.55 in 2021. Consequently, the increasing instances of infertility worldwide are driving the demand for fertility drugs, contributing to the growth of the fertility drug market.

Request Your Free Fertility Drugs Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2810&type=smp

Which Companies Are Leading the Charge in Expanding the Fertility Drugs Market?

Major companies operating in the fertility drugs market include Merck & Co., Ferring Pharmaceuticals Inc., Bayer AG, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer Inc., Novartis AG, Procter & Gamble Health Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, Serono Inc., Novagen Healthcare Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Schering-Plough Corporation, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Vitrolife, Cook Medical, Organon Group, The Cooper Companies Inc., Irvine Scientific, Genea Biomedx, Mankind Pharma

How Are Consumer Trends Shaping the Current and Future Landscape of the Fertility Drugs Market?

Leading firms in the fertility drugs market are placing their emphasis on the creation of innovative solutions such as peptide-based injectable treatments, with the aim of improving outcomes in reproductive health. These treatments make use of synthetic or natural peptides to stimulate or regulate hormone activity, specifically relating to fertility and reproductive health. As an illustration, Lupin Limited, a company based in India focused on pharmaceuticals, introduced a ganirelix acetate injection in the United States in February 2024. The medication is typically used in conjunction with assisted reproductive technology (ART) protocols to deter premature ovulation as women undergo in vitro fertilization (IVF) during controlled ovarian stimulation. Ganirelix acetate operates as a GnRH antagonist to assist in hormone level regulation, thereby allowing improved control over ovarian stimulation. The launch in the U.S showcases Lupin’s continued commitment to the expansion of its product range in the reproductive health arena and its dedication to meeting the needs of those receiving fertility treatments.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

What Are the Core Segments of the Fertility Drugs Market, and How Do They Contribute to Growth?

The fertility drugs market covered in this report is segmented –

1) By Type Of Drug: Prescription Fertility Drugs, Over-The-Counter Fertility drugs

2) By Route of Administration: Oral, Intravenous, Subcutaneous, Intramuscular

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Prescription Fertility Drugs: Gonadotropins, Clomiphene Citrate, Letrozole, GnRH Agonists, GnRH Antagonists, Progesterone

2) By Over-The-Counter Fertility Drugs: Ovulation Predictor Kits, Fertility Supplements, Fertility Monitors

What Are the Top Regions Fueling Growth in the Fertility Drugs Market?

The countries covered in the fertility drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

What Defines the Scope of the Fertility Drugs Market?

Fertility drugs refer to a term used to describe medications that cause your body to release hormones that regulate or prompt ovulation, or the release of an egg from your ovary.

Browse Through More Similar Reports By The Business Research Company:

IVF Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ivf-services-global-market-report

Assisted Reproductive Technology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

Hormonal Contraceptives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: